MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fate Therapeutics (FATE) Ownership - Who owns Fate Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
214.12M
P/E Ratio
N/A
Total Cash
296.92M
Projected Growth
N/A
Total Debt
98.98M
Revenue
13.45M
Risk (Beta)
2.20
Dividend Yield
N/A
Total Cash/Share
2.61
Total Debt/Equity
2.75
Revenue/Share
0.12 USD as % of share price
Fundamentals
FATE
Capitalization
214M
P/E Ratio
N/A
Risk (Beta)
2.20
Dividend Yield
N/A
Total Cash
297M
Total Cash/Share
2.61
Total Debt
99M
Total Debt/Equity
2.75
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
13.4M
ROE
N/A
Book Value
362M
P/B Ratio
0.59
Cash Flow
N/A
Earnings
-1.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
114K
Current Ratio
8.29
Current Revenue Per Employee
16983.43
Dividends Per Share - Security
N/A
EBITDA
-177.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.32
Shares Held By Institutions
529M
Shares Outstanding - Current
114M
Total Liabilities
133M
Total Volume MTD
N/A
Value
1
Gain YTD
-49.733
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com